Study Summary
This trial will assess a new tech-based solution to help therapists deliver evidence-based psychotherapies to people with mental illness and addiction, which could lead to better outcomes and reduce the global mental health burden.
- Therapies
- Cognitive Behavioral Therapy
Treatment Effectiveness
Effectiveness Progress
Study Objectives
8 Primary · 0 Secondary · Reporting Duration: Immediately before weekly therapy sessions for the duration of treatment or through study completion, a maximum of 18 months
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
LyssnCBT
1 of 2
SAU (services-as-usual)
1 of 2
Active Control
1957 Total Participants · 2 Treatment Groups
Primary Treatment: LyssnCBT · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:- Creed TA, Salama L, Slevin R, Tanana M, Imel Z, Narayanan S, Atkins DC. Enhancing the quality of cognitive behavioral therapy in community mental health through artificial intelligence generated fidelity feedback (Project AFFECT): a study protocol. BMC Health Serv Res. 2022 Sep 20;22(1):1177. doi: 10.1186/s12913-022-08519-9.
- Torrey Creed 2023. "AI-Based Fidelity Feedback to Enhance CBT". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05340738.
Frequently Asked Questions
Does this trial accept new participants?
"Clinicaltrials.gov reports that this investigation is actively enrolling participants, having been first advertised on the 9th of March and last revised 4 days later." - Anonymous Online Contributor